Samsung Biologics
Samsung Biologics is a South Korean biotechnology company recognized for its rapid growth and investment in large-scale biomanufacturing facilities. Established to provide contract manufacturing services for biopharmaceuticals, the company has emerged as a global leader in the industry, focusing on strategic expansions and partnerships to enhance its market position.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Samsung Biologics is pursuing an acquisition of Polypeptide to strengthen its position in the peptide manufacturing market.
7